In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies
Ημερομηνία
2022Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Individuals with β-thalassemia or sickle cell disease and hereditary persistence of fetal hemoglobin (HPFH) possessing 30% fetal hemoglobin (HbF) appear to be symptom free. Here, we used a nonintegrating HDAd5/35++ vector expressing a highly efficient and accurate version of an adenine base editor (ABE8e) to install, in vivo, a -113 A>G HPFH mutation in the γ-globin promoters in healthy CD46/β-YAC mice carrying the human β-globin locus. Our in vivo hematopoietic stem cell (HSC) editing/selection strategy involves only s.c. and i.v. injections and does not require myeloablation and HSC transplantation. In vivo HSC base editing in CD46/β-YAC mice resulted in > 60% -113 A>G conversion, with 30% γ-globin of β-globin expressed in 70% of erythrocytes. Importantly, no off-target editing at sites predicted by CIRCLE-Seq or in silico was detected. Furthermore, no critical alterations in the transcriptome of in vivo edited mice were found by RNA-Seq. In vitro, in HSCs from β-thalassemia and patients with sickle cell disease, transduction with the base editor vector mediated efficient -113 A>G conversion and reactivation of γ-globin expression with subsequent phenotypic correction of erythroid cells. Because our in vivo base editing strategy is safe and technically simple, it has the potential for clinical application in developing countries where hemoglobinopathies are prevalent. Copyright: © 2022, Li et al.
Collections
Related items
Showing items related by title, author, creator and subject.
-
The 5′ regulatory region of the human fetal globin genes is a gene conversion hotspot
Kalamaras, A.; Chassanidis, C.; Samara, M.; Chiotoglou, I.; Vamvakopoulos, N. K.; Papadakis, M. N.; Kollia, P.; Patrinos, G. P. (2008)The human fetal globin genes consist of the first mammalian genomic loci for which gene conversion was reported. To date, 14 gene conversions have been described in the human Gγ- and Aγ-globin genes, the vast majority of ... -
Real-World Adequacy of Glycaemic Control in Treatment-Naïve Greek Patients with Type 2 Diabetes Mellitus Initiating Treatment with Metformin Monotherapy at the Maximum Tolerated Dose: The Reload Study
Tsimihodimos V., Bargiota A., Pagkalos E.M., Manes C., Papas A., Karamousouli E., Voss B., Elisaf M.S. (2020)Background Metformin, in the absence of contraindications or intolerance, is recommended as first-line treatment for patients with type 2 diabetes mellitus (T2DM). This observational, retrospective study assessed the ... -
International comparison of glycaemic control in people with type 1 diabetes: an update and extension
Prigge R., McKnight J.A., Wild S.H., Haynes A., Jones T.W., Davis E.A., Rami-Merhar B., Fritsch M., Prchla C., Lavens A., Doggen K., Chao S., Aronson R., Brown R., Ibfelt E.H., Svensson J., Young R., Warner J.T., Robinson H., Laatikainen T., Rautiainen P., Delemer B., Souchon P.F., Diallo A.M., Holl R.W., Schmid S.M., Raile K., Tigas S., Bargiota A., Zografou I., Luk A.O.Y., Chan J.C.N., Dinneen S.F., Buckley C.M., Kgosidialwa O., Cherubini V., Gesuita R., Strele I., Pildava S., Veeze H., Aanstoot H.-J., Mul D., Jefferies C., Cooper J.G., Løvaas K.F., Battelino T., Dovc K., Bratina N., Eeg-Olofsson K., Svensson A.-M., Gudbjornsdottir S., Globa E., Zelinska N. (2022)Aims: To update and extend a previous cross-sectional international comparison of glycaemic control in people with type 1 diabetes. Methods: Data were obtained for 520,392 children and adults with type 1 diabetes from 17 ...